Los Angeles, CA, United States of America

Sergey Zozulya

USPTO Granted Patents = 2 


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2008-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Sergey Zozulya

Introduction

Sergey Zozulya is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of biomedical research, particularly in the area of cancer diagnostics and therapeutics. With a total of 2 patents, Zozulya's work focuses on innovative methods for detecting abnormal cell proliferation.

Latest Patents

Zozulya's latest patents include the invention titled "GEF-H1b: biomarkers, complexes, assays and therapeutic uses thereof." This invention relates to diagnosing abnormal cell proliferation in biological samples. It also involves screening for drugs that inhibit, reduce, or abolish cell growth, especially tumorigenic cell growth. The detection of a phosphovariant isoform of a guanine nucleotide exchange factor biomarker, such as the novel GEF-H1S, is a key aspect of this invention.

Career Highlights

Throughout his career, Zozulya has been associated with Sugen Incorporated, where he has contributed to various research projects. His work has been instrumental in advancing the understanding of cancer biology and developing potential therapeutic strategies.

Collaborations

Zozulya has collaborated with several professionals in his field, including Tod R Smeal and Marinella G Callow. These collaborations have enhanced the scope and impact of his research.

Conclusion

In summary, Sergey Zozulya is a prominent inventor whose work in cancer diagnostics and therapeutics has the potential to make a significant impact in the medical field. His innovative patents and collaborations reflect his commitment to advancing biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…